Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model
Author(s) -
BS Coller,
JD Folts,
LE Scudder,
Steven R. Smith
Publication year - 1986
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.v68.3.783.783
Subject(s) - antithrombotic , platelet , monoclonal antibody , ex vivo , thrombus , platelet membrane glycoprotein , fibrinolytic agent , medicine , in vivo , pharmacology , platelet glycoprotein gpiib iiia complex , platelet activation , platelet aggregation inhibitor , antibody , immunology , chemistry , in vitro , biology , biochemistry , microbiology and biotechnology
A murine monoclonal antibody directed at the platelet glycoprotein IIb/IIIa complex, which blocks platelet aggregation ex vivo, was tested for its antithrombotic effects in an established animal model of acute platelet thrombus formation in partially stenosed arteries. Infusion of 0.7 to 0.8 mg/kg of the F(ab')2 fragment of the antibody completely blocked new thrombus formation despite multiple provocations, making it the most potent antithrombotic agent tested in this model.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom